The relevance of systemic complications and the different outcomes of subgroups after Percutaneous Endoscopic Gastrostomy (PEG) [13]

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1951-1952

  Vakil, Nimish ^a   Morris, Anthony I ^b   Marcon, Norman ^b   Segalin, Andrea ^b   Peracchia, Alberto ^b   Bethge, Norbert ^b   Zuccaro, Gregory ^b   Bosco, John J ^b   Jones, Whitney F ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Sinai Samaritan Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; INFECTION PREVENTION; LETTER; MAJOR CLINICAL STUDY; MOUTHWASH; MULTICENTER STUDY; NEUROLOGIC DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR;

EID: 0034967994     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02478-9     Document Type: Letter

References (6)

1. Meta-analysis of randomised controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy
2. Cost analysis of antibiotic prophylaxis for PEG
3. A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy (PEG) significantly reduces local and systemic infective complications
4. Percutaneous endoscopic gastrostomy or jejunostomy and the incidence of aspiration in 79 patients
5. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) - Results from a prospective randomised multicenter trial
6. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: The Dutch Trauma Trial